This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Genethon, National Institute of Health and Medical Research, Université D'evry-Val-D'essonne. Active years: 2021-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 59 
2 out of 1,853 
1 out of 30 Years Active: 2021-2022
Title: Innovator Spotlight: Mirella Lo Scrudato
Introduction: Meet Mirella Lo Scrudato, an innovative inventor based in Paris, France, who has made significant contributions in the field of treating genetic disorders through her groundbreaking patents.
Latest Patents: Mirella Lo Scrudato's latest patents include "Compositions and methods for the treatment of myotonic dystrophy" and "Compositions and methods for the treatment of nucleotide repeat expansion disorders." These patents focus on developing effective treatments for genetic disorders such as myotonic dystrophy, showcasing her dedication to advancing medical science.
Career Highlights: With a total of 2 patents to her name, Mirella Lo Scrudato has demonstrated expertise in the development of novel compositions and methods for treating genetic disorders. Her work showcases a deep understanding of the complexities of conditions like myotonic dystrophy and a commitment to improving the lives of patients suffering from such diseases.
Collaborations: Throughout her career, Mirella Lo Scrudato has collaborated with esteemed organizations such as Genethon and Inserm (Institut National de la Santé et de la Recherche Médicale) to further research in the field of genetic disorders. Her partnership with Ana Maria Buj Bello, a prominent female figure in the industry, has led to innovative breakthroughs in treatment modalities for patients.
Conclusion: In conclusion, Mirella Lo Scrudato's pioneering work in the field of genetic disorder treatments highlights her as a visionary inventor dedicated to making a positive impact on healthcare. With a focus on innovation and collaboration, she continues to drive progress in the development of novel therapies for conditions such as myotonic dystrophy, inspiring the next generation of inventors in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile